Patents by Inventor Guy J. Creed

Guy J. Creed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for diagnosis of peripheral nerve damage
    Patent number: 5583201
    Abstract: Methods of diagnosing peripheral nerve damage, including diagnosing and monitoring chronic back and cervical pain are disclosed. The methods involve subjecting a body fluid sample from a patient suspected of having chronic lumbar or cervical pain and peripheral nerve damage to two-dimensional electrophoresis or an immunoassay and measuring relative amounts of protein or proteins which increase or decrease in concentration as compared to a standard control. A preferred method employs an Apo-E variant as a marker of peripheral nerve damage. Also disclosed are kits for use with the diagnostic methods.
    Type: Grant
    Filed: May 16, 1994
    Date of Patent: December 10, 1996
    Assignees: Monoclonetics International, Inc., United States of America as represented by the Department of Health and Human Services
    Inventors: Bruce M. Cameron, Sr., Carl R. Merril, Guy J. Creed, Dale VanderPutten
  • Methods for the diagnosis of peripheral nerve damage
    Patent number: 5364793
    Abstract: Methods of diagnosing peripheral nerve damage, including diagnosing and monitoring chronic back and cervical pain are disclosed. The methods involve subjecting a body fluid sample from a patient suspected of having chronic lumbar or cervical pain and peripheral nerve damage to two-dimensional electrophoresis or an immunoassay and measuring relative amounts of protein or proteins which increase or decrease in concentration as compared to a standard control. A preferred method employs an Apo-E variant as a marker of peripheral nerve damage. Also disclosed are kits for use with the diagnostic methods.
    Type: Grant
    Filed: December 1, 1992
    Date of Patent: November 15, 1994
    Assignees: Monoclonetics International, Inc., The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Bruce M. Cameron, Sr., Carl R. Merril, Guy J. Creed, Dale VanderPutten